From the publishers of JADPRO
CAR T-Cell Therapy
Resource Center
Menu
Resources
Videos
Videos
Fast Facts
Quizzes
News & Literature Highlights
Case Studies
Advertisement
Fast Facts #10: Viral Vectors and CAR T-Cell Therapy
Last Updated: Wednesday, March 16, 2022
Test your knowledge on viral vectors
Last Updated: Wednesday, March 16, 2022
Loading...
Advertisement
News & Literature Highlights
Journal of Translational Medicine
Asiaticoside enhances the antitumor efficacy of MSLN-targeted CAR-T cells in ovarian cancer
Trends in Cancer
In vivo CAR T cell engineering: Design principles and open questions
Blood Cancer Discovery
Multiomic and longitudinal dissection of immune dynamics associated with parkinsonism after ciltacabtagene autoleucel therapy
Blood Advances
Non-ICANS neurologic toxicity after BCMA CAR T: A systematic review and meta-analysis of 4630 multiple myeloma patients
Molecular Immunology
Navigating the frontier of CAR-T cell resistance: From underlying mechanisms to innovative therapeutic solutions
Cancer
Second-line chimeric antigen receptor T-cell therapy versus standard of care in relapsed or refractory large B-cell lymphoma: A systematic review and meta-analysis
Translational Oncology
Development and characterization of anti-CXCR4 chimeric antigen receptor T cells
Blood
How I treat HLH-like toxicities following immune effector cell therapy
Immunology
Strategies of AI-driven CAR-T cell therapy towards solid tumours
British Journal of Clinical Pharmacology
Efficacy, safety and cost-effectiveness of CAR-T therapy
Advertisement
Case Studies
Prophylactic Tocilizumab in Selected High-Risk or Outpatient CAR-T Populations
Hemophagocytic Lymphohistiocytosis Following CAR T-Cell Therapy in a Patient With Multiple Myeloma
Bloodless Medicine Management of a Patient Receiving CAR T-Cell Therapy
Fast Facts
Fast Facts #12: BCMA Targets
Advertisement
Quizzes
Test your knowledge of prophylactic strategies in selected high-risk or outpatient CAR-T populations
How much have you learned this year?
Test your knowledge of hemophagocytic lymphohistiocytosis following CAR T-cell therapy in a patient with multiple myeloma